Yandex has lifted partner-clinic restrictions, opening the beta version of its Yandex Med AI assistant to all doctors via a web interface and an Android app. An iOS version is promised later, with the system powered by Yandex AI Studio tech adapted for healthcare tasks.
The feature set is pragmatically focused on routine reference work: checking drug compatibility, sequencing prescribed tests, and validating clinical guidelines. The assistant integrates over 20 specialized medical calculators and clinical scales. To curb hallucinations, the processing pipeline breaks queries into stages: classifying the topic, selecting sources, and cross-referencing documents. Responses draw on more than 1,000 reference sources—from Health Ministry standards and ICD codes to pharmaceutical databases—citing direct links for every output.
The business logic behind the release is clear. Instead of a high-risk autonomous diagnostic tool, the market gets an advanced clinical search engine. By offering the tool for free to a broad professional base, Yandex builds habit among medical staff and gathers real-world usage data. This paves the way for enterprise healthcare monetization without the legal liability of direct diagnosis, leaving all clinical decisions strictly to human doctors.